Cambridge Investment Research Advisors’s iShares US Medical Devices ETF IHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$9.24M Sell
147,483
-17,942
-11% -$1.12M 0.03% 570
2025
Q1
$9.96M Sell
165,425
-7,843
-5% -$472K 0.03% 515
2024
Q4
$10.1M Sell
173,268
-13,489
-7% -$787K 0.03% 487
2024
Q3
$11.1M Sell
186,757
-12,250
-6% -$725K 0.04% 461
2024
Q2
$11.2M Sell
199,007
-10,666
-5% -$598K 0.04% 422
2024
Q1
$12.3M Sell
209,673
-8,462
-4% -$496K 0.05% 378
2023
Q4
$11.8M Sell
218,135
-84,039
-28% -$4.54M 0.05% 347
2023
Q3
$14.7M Sell
302,174
-42,412
-12% -$2.06M 0.07% 276
2023
Q2
$19.5M Buy
344,586
+33,393
+11% +$1.89M 0.09% 226
2023
Q1
$16.8M Sell
311,193
-29,745
-9% -$1.61M 0.08% 241
2022
Q4
$17.9M Sell
340,938
-37,300
-10% -$1.96M 0.09% 212
2022
Q3
$17.8M Sell
378,238
-13,066
-3% -$616K 0.1% 205
2022
Q2
$19.7M Sell
391,304
-12,450
-3% -$628K 0.11% 198
2022
Q1
$24.6M Sell
403,754
-26,585
-6% -$1.62M 0.11% 189
2021
Q4
$28.3M Sell
430,339
-2,203
-0.5% -$145K 0.13% 170
2021
Q3
$27.2M Sell
432,542
-40,246
-9% -$2.53M 0.13% 163
2021
Q2
$28.4M Buy
472,788
+450
+0.1% +$27.1K 0.14% 153
2021
Q1
$26M Sell
472,338
-26,142
-5% -$1.44M 0.14% 151
2020
Q4
$27.2M Buy
498,480
+72,240
+17% +$3.94M 0.16% 124
2020
Q3
$21.3M Buy
426,240
+45,192
+12% +$2.26M 0.14% 154
2020
Q2
$16.8M Buy
381,048
+141,306
+59% +$6.24M 0.13% 171
2020
Q1
$9M Sell
239,742
-44,652
-16% -$1.68M 0.09% 226
2019
Q4
$12.5M Buy
284,394
+24,264
+9% +$1.07M 0.1% 215
2019
Q3
$10.7M Sell
260,130
-54,012
-17% -$2.23M 0.09% 224
2019
Q2
$12.6M Buy
314,142
+74,928
+31% +$3.01M 0.12% 180
2019
Q1
$9.23M Buy
239,214
+70,122
+41% +$2.71M 0.09% 219
2018
Q4
$5.63M Buy
169,092
+15,786
+10% +$526K 0.06% 283
2018
Q3
$5.81M Buy
153,306
+54,222
+55% +$2.06M 0.06% 327
2018
Q2
$3.31M Buy
99,084
+14,934
+18% +$499K 0.04% 466
2018
Q1
$2.6M Sell
84,150
-3,174
-4% -$97.9K 0.03% 540
2017
Q4
$2.53M Buy
87,324
+23,886
+38% +$691K 0.03% 506
2017
Q3
$1.77M Sell
63,438
-28,908
-31% -$805K 0.02% 578
2017
Q2
$2.56M Buy
92,346
+54,576
+144% +$1.52M 0.04% 423
2017
Q1
$953K Buy
37,770
+6,942
+23% +$175K 0.02% 746
2016
Q4
$684K Sell
30,828
-10,512
-25% -$233K 0.01% 861
2016
Q3
$1M Sell
41,340
-18,306
-31% -$444K 0.02% 682
2016
Q2
$1.35M Buy
59,646
+33,990
+132% +$768K 0.03% 485
2016
Q1
$524K Buy
25,656
+1,536
+6% +$31.4K 0.01% 868
2015
Q4
$492K Sell
24,120
-3,714
-13% -$75.8K 0.01% 857
2015
Q3
$516K Sell
27,834
-7,164
-20% -$133K 0.01% 745
2015
Q2
$698K Buy
34,998
+3,984
+13% +$79.5K 0.02% 654
2015
Q1
$622K Buy
31,014
+3,600
+13% +$72.2K 0.02% 690
2014
Q4
$517K Buy
27,414
+1,134
+4% +$21.4K 0.02% 762
2014
Q3
$435K Buy
26,280
+1,848
+8% +$30.6K 0.01% 892
2014
Q2
$415K Buy
24,432
+1,434
+6% +$24.4K 0.01% 841
2014
Q1
$379K Buy
+22,998
New +$379K 0.01% 844